Meteora Capital’s Envoy Medical COCH Stock Holding History

Meteora Capital’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.2K	Hold	28,051	–	–	﹤0.01%	336
2026 Q1	$18.7K	Hold	28,051	–	–	﹤0.01%	297
2025 Q4	$18.5K	Buy	28,051 +681	+2%	+$539	﹤0.01%	284
2025 Q3	$21.2K	Buy	+27,370	New	+$37.1K	﹤0.01%	238
2024 Q1	–	Sell	-425,606	Closed	-$771K	–	280
2023 Q4	$771K	Hold	425,606	–	–	0.13%	132
2023 Q3	$2.99M	Buy	425,606 +140,822	+49%	+$1.41M	0.51%	54
2023 Q2	$2.92M	Sell	284,784 -120,000	-30%	-$1.21M	0.54%	57
2023 Q1	$4.07M	Buy	+404,784	New	+$4.06M	0.48%	65

Other funds holding COCH

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCA

DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACP

Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Meteora Capital's COCH Position: Q2 2026 in Review

Meteora Capital held its Envoy Medical (COCH) position steady in Q2 2026 at 28,051 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #336.

Meteora Capital first reported a position in COCH in Q1 2023 and has held it in 8 quarters since. The position peaked at $4.07M in Q1 2023. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

Meteora Capital held 28,051 shares of Envoy Medical worth $22.2K as of Q2 2026.
Meteora Capital left its Envoy Medical share count unchanged in Q2 2026.
Envoy Medical made up ﹤0.01% of Meteora Capital's portfolio in Q2 2026, its #336 holding.
Meteora Capital first reported a position in Envoy Medical in Q1 2023 and has held it in 8 quarters since.
Meteora Capital's Envoy Medical position peaked at $4.07M in Q1 2023.
32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Meteora Capital's 13F filing for Q2 2026, filed 14 Aug 2026.